APIA logo ABNOUS PODIA INVEST&ARCHITECT Inc. JA EN
DEEP TECH MATERIAL COMPANY FROM JAPAN

Engineering
the Future
of Biomaterials.

Abnous Podia Invest&Architect (APIA) is a research-driven company advancing the social implementation of frontier technologies.

Alongside in-house development of biomaterials built on formulation engineering, we discover technology seeds in Japan and abroad and develop applications across architecture, infrastructure, and living environments.

ABOUT

Applied
Biomaterial
Development.

APIA develops high-performance biomaterials by translating formulation technologies originally used for pharmaceuticals and medical devices into novel material systems for broader industrial applications.

Drug Delivery System (DDS) Our technical foundation lies in DDS technologies designed to deliver active agents to specific targets in the body. In pharmaceuticals and regenerative medicine, these systems protect compounds or cells with biocompatible gels and release or bind them in response to pH shifts or disease-related triggers. APIA applies that same molecular control to biomaterials with biodegradability, insolubility, water resistance, chemical resistance, solvent resistance, and condition-specific flexibility.
Upcycling Wasted Biomass We develop upcycling technologies that turn underused biomass into high-value functional materials. By using non-petroleum raw materials once treated as waste, we create safer and lower-impact alternatives. We also adapt concepts such as biocompatibility and bio-replacement from healthcare into material design pathways that balance biodegradability with industrial performance.
Deep Tech Investment From low-impact materials derived from unused biomass to inorganic chemistry inspired by dental treatments, biological formulations using living bacteria, and high-aesthetic bio-leather, we scout technology seeds across the Global South and beyond. We build alliances for application development and domestic market entry while assembling original international supply chains around local technologies.

Material technologies once cultivated for controlled release, stimuli-responsive dissolution, and texture design in biomedical use are being repurposed for construction materials, civil engineering products, and infrastructure systems.

By combining diverse feedstocks, including underused resources, with molecular-level structural control, we aim to build high-value materials that expand the conventional boundaries of biomaterials.

FOUNDING

Established in Tokyo, 2026

Abnous Podia Invest&Architect Inc.
CEO: Ryuto Kawamata
Address: 1-16-3 Yokokawa, Sumida-ku, Tokyo 130-0003, Japan

Founded on March 30, 2026.
The company was launched with support from Studio 10X (01Booster), a partner program of the Tokyo Metropolitan Government's startup initiative TOKYO SUTEAM.
We are advancing material development and commercialization with an initial focus on the construction and architecture sectors.

Ryuto Kawamata, Founder of Abnous Podia
Founder / Representative Director

Ryuto Kawamata

Ryuto Kawamata works across biomaterials, architecture, design, and technology to advance the social implementation of bio-derived materials.

He studied design, bioart, and technology at Kanazawa College of Art and IAMAS. At Abnous Podia, he leads material development, business concept design, prototyping, validation planning, and collaboration with municipalities and companies.

Biomaterials Architecture Design Technology
Full founder profile
BUSINESS

Three Core Platforms

01 / 02 / 03 We do not separate R&D, licensing, exit-use design, process development, and sales. Instead, we work backward from viable commercial channels and execute social implementation through one integrated planning philosophy from research through distribution.
01

Advanced Biomaterials

Research, development, and supply of high-performance biomaterials.
We design not only for functional performance, but also for manufacturability, regulatory fit for architectural implementation, and international scalability, guided by downstream products and sales strategy.

02

Material Licensing

IP development and licensing of material technologies.
Beyond exporting finished products, we package manufacturing methods themselves as transferable process systems, explore licensees, and structure optimal agreements including royalty arrangements.

03

Project Development

From material development and technology-seed selection to realistic go-to-market business planning, we design commercialization as one integrated process and build benefit-sharing schemes that stakeholders can sustain as the technology is actually deployed.

CAPABILITIES

Biomaterials / Products / Technology Seeds

Flame-Retardant / Waterproof Wood

We process wood into composite timber materials by impregnating porous internal structures with a range of functional agents.
By adding flame resistance, water resistance, anti-mold, anti-termite, and weatherability, we expand the use cases of wood into applications that were previously difficult to realize.

Biodegradable Materials

Using naturally derived feedstocks, we control polymer interactions such as polyion complexes, coordination, crosslinking, and polycondensation to introduce biodegradability and sustained-release behavior under targeted conditions.

Biomaterial Wallpaper

A bio-based material system applying composites made from biological feedstocks to wallpaper and facade surfaces.
Through fermentation, calcification, and other composite-forming processes centered on underused biomass, we provide non-petroleum, low-impact building materials with novel textures, together with installation adhesive systems.

Bacterial Manufacturing

We solve living-environment challenges by using beneficial bacteria themselves, their secreted enzymes, and antimicrobial peptides as active ingredients.
Offerings include industrial bio-deodorizers made by powdering live deodorizing bacteria, bio-concrete that self-repairs through bacterial activity, and soil-regeneration agents that rebalance microbial ecosystems in abandoned farmland.

Formulation Engineering

We apply formulation know-how to design processing methods for controlled release and molecular delivery, including DDS, sustained release, pH-dependent dissolution, and optimization of in-system material behavior.

PROJECTS

Materials / Products / Deployment

We are currently advancing multiple projects across material development, productization, and business deployment.

Flame-retardant wood

Flame-Retardant Wood

Plant-derived flame-retardant timber created by impregnating wood with a range of non-combustible agents.

Biomaterial wallpaper

Biomaterial Wallpaper

Production of biomass-derived bio-leather through bacterial fermentation and its application to wall coverings.

Lica casein adhesive

Lica

A 100% natural-origin powder premix adhesive based on calcified casein chemistry.

Bio deodorizer

Safu

A long-lasting bio deodorizer for drainage systems, made with living soil-derived deodorizing bacteria.

Insecticidal bacterial formulation

Insecticidal Bacterial Formulation

A bacterial insecticide that targets only mosquitoes and flies.

Remia calcified colophonium

Remia

A plant-derived biodegradable penetrating-hardening polymer made by polymerizing pine resin and metal pigments.

Ovidium wood wax

Ovidium

A 100% natural matte wood wax combining pine pollen and carnauba wax.

Plant-derived soil regeneration agent

Plant-Derived Soil Regeneration Agent

An agricultural input that resets soil microbial balance through plant-based biofumigation components and restores a healthier biological environment for crop growth.

Plant-derived soap

Plant-Derived Soap

A lower-impact soap formulated with plant-derived surfactants and antimicrobial ingredients.

INVESTMENT

Capital for Implementation

Early-Stage Investment

Investment in advanced materials and architecture-related technologies at an early stage.

Strategic Joint Ventures

Joint development with manufacturing and construction partners.

Asia Expansion

A platform for deploying Japanese technologies across Asia.

CONTACT

For partnership, investment,
and material collaboration inquiries.